Tamara Syrek Jensen, Director
Joseph Chin, MD, Deputy Director
Coverage and Analysis Group
Centers for Medicare & Medicaid Services
7500 Security Blvd.
Baltimore, Maryland 21244
SUBJECT: Request for Reconsideration of CMS National Coverage Determination (NCD) 20.7: Percutaneous Transluminal Angioplasty (PTA)
Dear Ms. Syrek Jensen and Dr. Chin:
On behalf of the American Association of Neurological Surgeons (AANS), the Congress of Neurological Surgeons (CNS) and the AANS/CNS Joint Section on Cerebrovascular Neurosurgery, we appreciate the opportunity to comment on the reconsideration of National Coverage Determination (NCD) 20.7: Percutaneous Transluminal Angioplasty (PTA). Neurosurgeons perform carotid artery stenting (CAS) and carotid endarterectomy (CEA), positioning us to objectively evaluate the clinical evidence for treating carotid artery disease.
Click here to view the full Neurosurgery Urges CMS to Revisit Medicare Coverage Policy for Carotid Stenting.
